ID: ALA185737

Max Phase: Preclinical

Molecular Formula: C20H21NO2

Molecular Weight: 307.39

Molecule Type: Small molecule

Associated Items:

Representations

Canonical SMILES:  COc1ccc2c(c1)CC/C(=C\c1cccc(N(C)C)c1)C2=O

Standard InChI:  InChI=1S/C20H21NO2/c1-21(2)17-6-4-5-14(12-17)11-16-8-7-15-13-18(23-3)9-10-19(15)20(16)22/h4-6,9-13H,7-8H2,1-3H3/b16-11+

Standard InChI Key:  KHVSGLYJABKRDI-LFIBNONCSA-N

Associated Targets(non-human)

Cytochrome P450 24A1 20 Activities

Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: Small moleculeTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Properties

Molecular Weight: 307.39Molecular Weight (Monoisotopic): 307.1572AlogP: 3.97#Rotatable Bonds: 3
Polar Surface Area: 29.54Molecular Species: NEUTRALHBA: 3HBD: 0
#RO5 Violations: 0HBA (Lipinski): 3HBD (Lipinski): 0#RO5 Violations (Lipinski): 0
CX Acidic pKa: CX Basic pKa: 4.73CX LogP: 4.29CX LogD: 4.29
Aromatic Rings: 2Heavy Atoms: 23QED Weighted: 0.80Np Likeness Score: -0.48

References

1. Yee SW, Simons C..  (2004)  Synthesis and CYP24 inhibitory activity of 2-substituted-3,4-dihydro-2H-naphthalen-1-one (tetralone) derivatives.,  14  (22): [PMID:15482941] [10.1016/j.bmcl.2004.08.040]

Source